Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Significance: Chemical diversity has recently risen as key structural feature for the discovery of novel selective drugs of G protein-coupled receptors (GPCRs). However, the traditional drug discovery technique of combinatorial chemistry coupled to high-throughput screening has become less attractive because of its immense financial impact. To address this problem, we implemented a computer-aided drug design approach, using the M 2 muscarinic acetylcholine receptor (mAChR) as a GPCR model, and performed computational enhanced sampling simulations to account for the receptor flexibility. Through iterative molecular docking and experimental testing, half of the 38 computationally selected National Cancer Institute compounds were validated as allosteric modulators of the M 2 mAChR. Our method successfully identified positive and negative allosteric modulators of M 2 mAChR with unprecedented chemical diversity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cambridge Structural Database
Groom, C. R., Bruno, I. J., Lightfoot, M. P., & Ward, S. C. (2016) · Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials · doi:10.1107/s2052520616003954 · Cited by 10,297 · cited 2×
“This work can also provide useful guidance for future drug design efforts using larger chemical databases [e.g., ZINC (49) and ChemBridge (50)], targeting allosteric sites of the M 2 receptor and other medically important GPCRs.”
BackgroundHow many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
Self-citationEmerging paradigms in GPCR allostery: implications for drug discovery
Wootten, D., Christopoulos, A., & Sexton, P. M. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4052 · Cited by 498 · cited 1×
“Combining their modulatory effects with their potential for selective interaction with less conserved binding sites, allosteric modulators represent an alternate therapeutic approach to treat GPCR-related diseases (14, 15).”
BackgroundSelf-citationMuscarinic acetylcholine receptors: novel opportunities for drug development
Kruse, A. C., Kobilka, B. K., Gautam, D., Sexton, P. M., Christopoulos, A., & Wess, J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4295 · Cited by 437
Self-citationStrategies to Discover Unexpected Targets for Drugs Active at G Protein–Coupled Receptors
Allen, J. A., & Roth, B. L. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100553 · Cited by 216 · cited 1×
“Many receptor subtypes of GPCR families often exhibit a highly conserved orthosteric binding pocket, such that a single ligand can interact with several receptors simultaneously, leading to the activation/inactivation of multiple receptors, sometimes with opposing of their signaling profiles, contributing to off-targe…”
Background
Cited by
Common activation mechanism of class A GPCRs
Zhou, Q., Yang, D., Wu, M., Guo, Y., Guo, W., Zhong, L., Cai, X., Dai, A., Jang, W., Shakhnovich, E. I., et al. (2019) · eLife · doi:10.7554/elife.50279 · Cited by 632
G protein-coupled receptors: structure- and function-based drug discovery
Yang, D., Zhou, Q., Labroska, V., Qin, S., Darbalaei, S., Wu, Y., Yuliantie, E., Xie, L., Tao, H., Cheng, J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00435-w · Cited by 632
Molecular dynamics simulations and novel drug discovery
Liu, X., Shi, D., Zhou, S., Liu, H., Liu, H., & Yao, X. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1403419 · Cited by 518
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Zhang, M., Chen, T., Lu, X., Lan, X., Chen, Z., & Lu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01803-6 · Cited by 491
Ensemble Docking in Drug Discovery
Amaro, R. E., Baudry, J., Chodera, J., Demir, Ö., McCammon, J. A., Miao, Y., & Smith, J. C. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.02.038 · Cited by 479
Self-citation
Metadata
- Authors
- Miao, Y., Goldfeld, D. A., Moo, E. V., Sexton, P. M., Christopoulos, A., McCammon, J. A., & Valant, C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2016-09-06
- Volume
- 113
- Issue
- 38
- Pages
- E5675-84
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2520646257
- Cited by
- 89
- References
- 6
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor. https://app.cochat.ai/papers/10.1073/pnas.1612353113
- The paper
- Miao, Y., Goldfeld, D. A., Moo, E. V., Sexton, P. M., Christopoulos, A., McCammon, J. A., & Valant, C. (2016). Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1612353113
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.